Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows

v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities      
Net loss $ (8,244,372) $ (7,347,903)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Share-based compensation expense 189,425 245,295  
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (531,362) 337,919  
Accounts payable (826,591) (537,301)  
Accrued liabilities (2,970,620) 2,375,124  
Net cash used in operating activities (12,383,520) (4,926,866)  
Cash flows from financing activities      
Proceeds from issuance of Common Shares, pre-funded warrants, and common warrants from January 29, 2026 PIPE, net of issuance costs 70,081,309    
Net cash provided by financing activities 70,081,309    
Net increase (decrease) in cash 57,697,789 (4,926,866)  
Cash at beginning of period 6,116,556 13,291,167 $ 13,291,167
Cash at end of period 63,814,345 8,364,301 $ 6,116,556
Noncash financing activities      
Increase (decrease) in share-based compensation liability on CAD denominated share options (decreasing) increasing additional paid-in-capital $ 50,198 $ (86,163)